The models are not offered as a chat-based product; instead, Basecamp will use them in collaboration with pharmaceutical companies to design therapeutics.

Basecamp plans ongoing refinement of the BaseData dataset, the EDEN models, and the aiPGI platform ahead of Series C, amid sustained industry interest in AI-driven biodesign.

A companion paper detailing the programmable therapeutics and AI design process is available through Basecamp Research’s site, outlining the methodology and collaboration.

Basecamp Research has unveiled world-first AI models for programmable gene insertion (aiPGI), powered by the EDEN evolutionary AI suite developed with NVIDIA, to enable large DNA insertions at precise genomic sites for potential curative cell and gene therapies.

In lab tests, the platform achieved insertions at more than 10,000 disease-related genomic locations and produced CAR-T cells that achieved over 90% tumor-cell clearance in assays.

The EDEN models were trained on an exceptionally large, ethically sourced dataset—over 10 trillion tokens of evolutionary DNA from more than a million species, with data collected across 150 locations in 28 countries.

Basecamp has secured investment from Nvidia’s venture arm NVentures in a pre-Series C round, though the investment amount was not disclosed.

Overall, Basecamp Research has raised about $85 million to date, backed by investors including Singular, True Ventures, Hummingbird Ventures, and Paul Polman.

Nvidia CEO Jensen Huang has highlighted Basecamp as a strategic UK startup in Nvidia’s broader £2 billion push to bolster the UK AI industry.

The company says it can operate with a smaller budget than many US AI labs by tailoring data size to model size and using lab-generated data to cut costs.

Lab results, published with Nvidia, Microsoft, and leading academics, show multiple active insertion proteins across tested disease-relevant target sites.

Basecamp released a joint paper with Nvidia, Microsoft, and academia, and unveiled the aiPGI models at Nvidia’s JP Morgan Healthcare Conference presentation in the US.